Australian Pharmaceutical Biostatistics Group (APBG) Mid-Year Meeting 

Mark your calendars - the highly anticipated APBG mid-year meeting will be held on 28th July in North Sydney, 2pm to 4.30pm!

This year we will delve into the fascinating realm where Statistics and Pharmacokinetics intersect, with an exclusive presentation from renowned statistician and pharmacokineticist Glynn Morrish, Owner and Director of Remedy Research.

All SSA members are warmly invited to join us in person for refreshments and networking. For added convenience, the event will also be accessible online. Please RSVP to apbgsteering@gmail.com for the address and online meeting details. We look forward to seeing you there!

Date/Time

28th July 2023, 2pm to 4.30pm

Location

North Sydney

Agenda

2pm Tea, coffee and networking

2.30pm Presentation by Glynn Morrish – Pharmacokinetics and Statistics: When two become one (an untold love story?)

4pm Afternoon tea and networking

4.30pm Meeting Close

RSVP: email apbgsteering@gmail.com for address and online meeting link

Pharmacokinetics and Statistics: When two become one (an untold love story?)

Speaker: Glynn Morrish (Remedy Research)

Abstract: A key objective throughout the drug development process is to understand exposure of the investigational product, how exposure relates to efficacy and safety, and how exposure may change with different populations and administration regimens. Pharmacokinetics is the study of how the body interacts with administered products and determines exposure. In the analysis of pharmacokinetic data, rigorous and robust statistical methodology must be applied to ensure appropriate outcomes and accurate reporting are achieved. Further to this, the recent and future advancement of the pharmacometrics domain heavily relies on the application of advanced statistical concepts. This presentation will provide an introduction to clinical pharmacokinetics, describe non-compartmental and model-based pharmacokinetic analysis methods, and discuss the statistical methodology and techniques that are applied to various drug development objectives.

Biography: Glynn Morrish is the Director of Remedy Research, a consultancy organization providing pharmacokinetic and statistical analysis services to the drug/device development industry. Glynn has over 20 years' experience in clinical research and data analysis, both in industry and academic settings. He has a deep passion for biostatistical and pharmacometric analysis and its application to the drug/device development process; demonstrated by his contribution to the development of over 100 pharmaceutical products, authoring of peer-reviewed publications, conduct of non-for-profit and commercial courses in clinical data modelling and simulation, and the supervision of post-graduate research students.